E-poster No. / 壁報編號
C17
Title / 題目
Efficacy and Safety Report of a Randomized Controlled Trial of Tucidinostat in Combination with Exemestane in Postmenopausal Taiwanese Patients with Hormone Receptor-Positive Advanced Breast Cancer
First Author / 第一作者
Fu Ou-Yang
Institution / 單位
Kaohsiung Medical University Chung-Ho Memorial Hospital
Audio / 音訊檔
Author Group / 作者群
Liang-Chih Liu(2), Yuan-Ching Chang(3), Chia-Lun Chang(4), Ming-Shen Dai(5), Shih-Hsin Tu(6), Dar-Ren Chen(7), Ye-Su Chao(8), Chia-Nan Chen(8), Tsu-Yi Chao(9*)
Author Group Institution/ 作者群單位
(2)China Medical University Hospital, Taichung, Taiwan; (3)Taipei Mackay Memorial Hospital, Taipei, Taiwan; (4)Taipei Municipal Wan Fang Hospital,Taipei, Taiwan; (5)Tri-Service General Hospital, Taipei, Taiwan; (6)Taipei Medical University Hospital, Taipei, Taiwan; (7)Changhua Christian Hospital, Changhua, Taiwan; (8)GNT (Great Novel Therapeutics) Biotech & Medicals Corporation, Taipei, Taiwan; (9)Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan
Category / 主題分類
Clinical Research
Keyword / 關鍵字
Endocrine therapy resistance、HR+ advanced breast cancer、Phase III trial、tucidinostat, exemestane
